Temperature Management During Sedation for Endoscopic Retrograde Cholangiography
Conditions
Keywords
sedation, endoscopic retrograde cholangiography, temperature managment, hypothermia
Brief summary
The aim of this prospective observational study is to evaluate the role of a convective warming blanket to prevent hypothermia during sedation for an endoscopic retrograde cholangiography (ERC).
Detailed description
During endoscopic retrograde cholangiography (ERC), deep medical sedation of the patient is routinely perform. Since ERC is a complex examination and in addition sometimes several intervention steps are necessary (bougienage, dilatation, brush cytology, specimen collection, insertion of plastic and metal stent prostheses), the sedation time is almost always \> 30min, in many cases even up to one hour or longer. These patients are at risk for developing hypothermia (drop in core body temperature below 36 degrees Celsius). It is well known from anesthesiologic research that even moderate perioperative hypothermia, however, can have potentially serious complications. These include increased mortality, cardiac complications such as arrhythmias and infarctions, coagulation disorders, and increased transfusion requirements and wound infections. Changes in serum concentrations of potassium and peripheral vasoconstriction with decrease in subcutaneous partial pressure of oxygen are also clinically important side effects of perioperative hypothermia. However, the current 2014 German S3 guideline Sedation in gastrointestinal endoscopy does not mention peri- or intra-interventional temperature measurement or temperature management. The aim of this prospective observational study is to evaluate the role of a convective warming blanket to prevent hypothermia during sedation for an ERC. From the description of various clinical endpoints, we seek to obtain sufficient evidence to support routine use of such a system in ERC examinations. This study has the potential to set the new standard for modern sedation during ERC interventions that recognizes the risk of hypothermia and identifies a strategy to avoid it. For this purpose, we will use a device, that is already routinely used in all operation rooms in Germany, the so-called warm air device Twinwarm, Generation III. This device has a valid CE mark and will be used according to its purpose pre-, intra- and postoperative maintenance of the normothermic body temperature of the patient. The device will be used strictly in accordance with the existing in-house SOP Heat Management of 04/2021 of the Department of Anesthesiology and Intensive Care Medicine of Hannover Medical School (MHH).
Interventions
DEVICEForced Air Heating Temperature control Twinwarm II
For this purpose, we will use a device that is already routinely used in all operation rommss at MHH, the so-called warm air device Twinwarm, Generation III. This device has a valid CE mark and will be used according to its purpose pre-, intra- and postoperative maintenance of the normothermic body temperature of the patient. The device will be used strictly according to the existing in-house SOP Heat Management of 04/2021 of the Department of Anesthesiology and Intensive Care Medicine of the MHH. Convective air heating has been shown to be effective in many studies and can be used flexibly with a variety of different ceiling models.
Sponsors
Hannover Medical School
Study design
Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Indication to receive repeat (≥ 2 expected interventions) endoscopic retrograde cholangiography (ERC) (The following underlying conditions may be considered as indications for repeat ERC to be performed: * Primary sclerosing cholangitis (PSC) * Ischemic type biliary lesion (ITBL) after liver transplantation (LTX) * Anastomotic stenosis after LTX * Secondary sclerosing cholangitis (SSC)) * necessary intravenous medical sedation is expected to be required \>30min (female and male, age ≥ 18 years).
Exclusion criteria
* Patients \< 18 years * Pregnant women
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Highest absolute change of T from baseline at any time during intervention as well as at the end of intervention | During Intervention | Primary Endpoint |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of patients with a reduction of T from baseline more than 1 degree Celsius at any time during intervention as well as at the end of intervention | During Intervention | Key Secondary Endpoint |
| Percentage of patients with a reduction of T below 36 degree Celsius at any time during intervention as well as at the end of intervention | During Intervention | Percentage of patients with a reduction of T below 36 degree Celsius |
| Hemodynamic stability | During Intervention | Mean arterial pressure (MAP) * Lowest absolute MAP (mmHg) * Percentage of patients with a reduction of MAP of at least 25% from baseline * Absolute change of MAP below 65mmHg from baseline Heart Rate: * Relative difference: Percentage of patients with an increase of HR of at least 25% from baseline * Percentage of patients with a increase of heart rate \> 100bpm Intravenous fluids: * Percentage of patients (%) needing intravenous fluid support for hemodynamic stability * Cumulative total Volume (ml) of intravenous fluid support Vasoactive substances: \- Percentage of patients (%) needing vasoactive substance support |
| Respiratory Stability | During Intervention | peripheral Oxygen Saturation (O2-Sat) \- Percentage of patients with a reduction of O2-Sat below 90% Oxygen support: * Percentage of patients needing \> 2l/min oxygen * Maximum needed flow (l/min) of oxygen delivery Further adverse events: * Percentage of patients (%) needing mask ventilation * Percentage of patients (%) with need for Guedel or Wendel tube insertion |
| Subjective Patient Satisfaction | 6 hours after intervention | Subjective Freezing (VAS 0-10 points, with higher scores indicating more intense freezing) Quality of Recovery (QoR) Score by Myles et al. (Use of the German Modifikation by Eberhart et al) with score ranging from 0 to 18 points and higher scores indicating more discomfort with anesthesia modified DGAI Score with score ranging from 0 to 9 points and higher scores indicating more discomfort with anesthesia |
Countries
Germany
Contacts
Primary ContactKlaus Stahl, PD Dr. med.
Backup ContactHenrike Lenzen, PD Dr. med.
Outcome results
None listed